Lilly presents trial data on Alzheimer’s drug showing promise
Extent of COVID-19 vaccine waste remains largely unknown
15 March 2021Lab studies of emotion and well-being may be missing real-world anxiety
15 March 2021Lilly presents trial data on Alzheimer’s drug showing promise
Eli Lilly & Co. presented highly anticipated details from a mid-stage study showing that its experimental drug modestly slowed Alzheimer’s disease progression over about 18 months.
